← Back to Search

Group Written Exposure Therapy for PTSD (GWET Trial)

N/A

Recruiting

Led By Jenna Boyd, Ph.D.

Research Sponsored by St. Joseph's Healthcare Hamilton

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 week before treatment begins, 1 week after treatment ends, and 1-month follow-up.

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if Written Exposure Therapy (WET) is effective when done in a group setting for patients with post-traumatic stress disorder (PTSD). They want to know if group W

Who is the study for?

This trial is for adults aged 18-65 with PTSD who can read and write in English. They must be able to give informed consent. It's not clear what excludes someone from participating, but typically it would involve factors that could interfere with the treatment or data collection.

What is being tested?

The trial tests Group Written Exposure Therapy (WET) for PTSD, comparing its effectiveness and dropout rates against group Cognitive Processing Therapy (CPT). Participants will attend six weekly online sessions led by therapists and complete symptom questionnaires over time.

What are the potential side effects?

While specific side effects are not listed, psychological therapies like WET may sometimes cause temporary increases in distress due to discussing traumatic events, which should be monitored by the therapists.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ weekly at each group session, 1 week before treatment begins, 1 week after treatment ends, and 1-month follow-up.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~weekly at each group session, 1 week before treatment begins, 1 week after treatment ends, and 1-month follow-up.

This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly at each group session, 1 week before treatment begins, 1 week after treatment ends, and 1-month follow-up. for reporting.